Perspective Therapeutics (CATX) Market Capitalization (2010 - 2026)

Perspective Therapeutics has disclosed Market Capitalization across 17 years of filings, most recently posting $389.0 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 52.28% year-over-year to $389.0 million; the TTM figure through Jun 2026 stood at $389.0 million (up 52.28% YoY), while the FY2025 annual figure was $204.4 million, down 9.32% from the prior year.
• Market Capitalization came in at $389.0 million for Q2 2026 at Perspective Therapeutics, down from $475.5 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $902.0 million in Q3 2024 to a low of $32.7 million in Q3 2022.
• Average Market Capitalization over 5 years is $273.4 million, with a median of $196.2 million recorded in 2023.
• Year-over-year, Market Capitalization surged 1090.64% in 2024 and tumbled 77.42% in 2025.
• Over 5 years, Market Capitalization stood at $35.5 million in 2022, then jumped by 217.28% to $112.7 million in 2023, then surged by 99.99% to $225.4 million in 2024, then slipped by 9.32% to $204.4 million in 2025, then surged by 90.3% to $389.0 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $389.0 million in Q2 2026, $475.5 million in Q1 2026, and $204.4 million in Q4 2025.